Overview

Opioid-sparing Effect of Intravenous Ibuprofen

Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The investigators aimed to evaluate tramadol-sparing effect of intravenous (IV) ibuprofen in patients undergoing percutaneous nephrolithotomy (PCNL).
Phase:
Phase 4
Details
Lead Sponsor:
Muharrem Ucar
Treatments:
Acetaminophen
Ibuprofen